Back to Gene
F7 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

F7 gene

The F7 gene provides instructions for making coagulation factor VII, a protein that plays a critical role in the coagulation system to form blood clots after injury.

Normal Function

The F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins involved in the coagulation system, a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.

Coagulation factor VII is made primarily by cells in the liver. The protein circulates in the bloodstream in an inactive form until the coagulation system is turned on (activated) by an injury that damages blood vessels. Activated coagulation factor VII helps turn on other coagulation factors in turn. This step-wise process ultimately promotes the conversion of an important coagulation protein called fibrinogen into fibrin, which is the material that forms blood clots.

Health Conditions Related to Genetic Changes

Factor VII deficiency

Almost 300 mutations in the F7 gene have been found to cause a rare bleeding disorder called factor VII deficiency. This disorder commonly causes:

  • Nosebleeds
  • Easy bruising
  • Bleeding of the gums
  • Prolonged or excessive bleeding following surgery or physical injury

In severe cases, life-threatening episodes of bleeding inside the skull or gastrointestinal tract can occur. The F7 gene mutations involved in this condition reduce the amount of coagulation factor VII in the bloodstream. A shortage of coagulation factor VII prevents blood from clotting normally, causing episodes of abnormal bleeding that can be severe.

Frequently Asked Questions

Patients with factor VII deficiency often notice frequent nosebleeds, easy bruising, or bleeding gums. In some cases, they may experience prolonged bleeding after minor cuts, dental work, or surgery. Severe cases can present with spontaneous internal bleeding, such as into the brain or gastrointestinal tract, which requires immediate medical attention.
Diagnosis typically involves a coagulation panel that includes prothrombin time (PT) and activated partial thromboplastin time (aPTT). A prolonged PT with a normal aPTT is suggestive of factor VII deficiency. Confirmation is obtained by measuring factor VII activity levels and genetic testing to identify specific F7 mutations.
cute bleeding can be treated with recombinant factor VIIa (rFVIIa) or plasma-derived factor VII concentrates. For ongoing management, prophylactic infusions of factor VII may be scheduled, especially before surgeries or dental procedures. In some patients, vitamin K supplementation can help if deficiency is due to malabsorption or liver disease.
voiding medications that impair platelet function (e.g., aspirin, NSAIDs) and using caution with anticoagulants are important. Maintaining good oral hygiene, using a soft toothbrush, and wearing protective gear during sports can help. Patients should also keep a bleeding diary and inform healthcare providers before any invasive procedures.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA